Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2026-03-09 @ 1:57 AM
Study NCT ID:
NCT00579527
Status:
COMPLETED
Last Update Posted:
2022-03-25
First Post:
2007-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I/II Thymus Transplantation With Immunosuppression #950
Sponsor:
Sumitomo Pharma Switzerland GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-20
First Submit QC Date:
None
Study First Post Date:
2007-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-12-27
Results First Submit QC Date:
None
Results First Post Date:
2020-02-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-01-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2022-03-23
Last Update Post Date:
2022-03-25
Last Update Post Date Type:
ACTUAL